Standout Papers

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance 2020 2026 2022 2024429
  1. PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance (2020)
    Maddison Rose, Joshua T. Burgess et al. Frontiers in Cell and Developmental Biology

Immediate Impact

46 standout
Sub-graph 1 of 19

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
H2AX: A key player in DNA damage response and a promising target for cancer therapy
2024 Standout
2 intermediate papers

Works of Maddison Rose being referenced

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
2020 Standout

Author Peers

Author Last Decade Papers Cites
Maddison Rose 337 341 98 7 558
Minhong Tang 331 252 68 14 541
Shannon L. Gibson 412 229 193 7 533
Galina Semenova 407 221 91 7 566
Minalini Lakshman 296 202 113 8 520
Carine Robert 505 229 64 12 603
Raquel Batlle 338 226 184 7 542
Patrycja Tudrej 250 179 150 8 519
Longyue L. Cao 409 204 81 9 576
Milena Dürrbaum 354 168 149 10 605
Junli Deng 320 193 173 7 480

All Works

Loading papers...

Rankless by CCL
2026